medical research

6 items

RESEARCHarXiv CS.LG·5/8/2026

Nationwide EHR-Based Chronic Rhinosinusitis Prediction Using Demographic-Stratified Models

This study leverages nationwide longitudinal EHR data from the All of Us Research Program to predict chronic rhinosinusitis (CRS) diagnosis using two years of pre-diagnostic history. It implements a hybrid feature-selection pipeline to address data sparsity and dimensionality, aiming to overcome limitations of single-institutional cohorts and improve population-level generalizability.

Healthcare predictive modeling chronic rhinosinusitis medical research

RESEARCHarXiv CS.AI·4/20/2026

DeepER-Med: Advancing Deep Evidence-Based Research in Medicine Through Agentic AI

DeepER-Med introduces an agentic AI framework for deep evidence-based medical research, enhancing trustworthiness and transparency. It provides explicit evidence appraisal criteria and improves benchmarking for complex, real-world medical questions.

evidence-based AI AI in healthcare trustworthy AI Agentic AI

CASEGoogle DeepMind Blog·24d ago

Accelerating discovery of liver disease mechanisms

Filippo Menolascina uses Co-Scientist to identify new liver disease treatments. The tool also helps explain why existing drugs only benefit certain patients.

liver disease AI applications drug discovery Co-Scientist

Accelerating discovery of liver disease mechanisms

ARTICLEDEV.to AI·4/9/2026

ALS Has 30,000 American Patients and 150 Specialized Centers. None of Them Route Their Outcome Intelligence to Each Other.

O conteúdo descreve a Esclerose Lateral Amiotrófica (ELA), uma doença fatal sem cura, detalhando sua prevalência e a limitada eficácia dos tratamentos existentes. No entanto, o título destaca a falta de compartilhamento de 'inteligência de resultados' entre os centros, indicando um cenário propício para a aplicação de soluções de IA para integração e análise de dados.

ALS Healthcare Data data sharing rare diseases

NEWSGoogle DeepMind Blog·24d ago

Uniting biological toolkits for a new approach to ALS

Co-Scientist is facilitating a collaboration between Boston Children’s Hospital and MIT to investigate novel RNA-based therapies for Amyotrophic Lateral Sclerosis (ALS). This initiative aims to develop new treatment approaches by combining their biological toolkits.

ALS medical research RNA treatments Collaboration

Uniting biological toolkits for a new approach to ALS

RESEARCHDEV.to AI·5/9/2026

The Repurposing

Researchers at Tohoku University found that lubiprostone, a generic constipation drug, unexpectedly slows the decline of chronic kidney disease. The study revealed the drug preserves kidney function by reshaping the gut microbiome, rather than by clearing uremic toxins as initially hypothesized.

gut microbiome lubiprostone chronic kidney disease medical research